TEM NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Tempus AI, Inc. Class A Common Stock · Healthcare · Health Information Services

Open interactive chart View report data Download investor PDF
Latest close 42.69 USD
-18.6% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -19.6% below the Trend Line and sits at 1.5% of its 52-week range. The latest completed week returned -18.6%, after a -24.0% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is mixed with 37/100 conviction, while the latest news-sentiment score is 50/100. Near-term considerations: earnings are due in 0d.

Setup score 21 out of 100
Latest Close 42.69 USD 24 Jul 2026
1W Return -18.6% latest completed week
4W Return -24.0% short-term follow-through
12W Return -22.4% quarterly tape
Trend Breadth 38.5% 20 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 43.78% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -18.6% Latest completed week; four-week move -24.0%. Indicator stack 21/56 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 43.78% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Mixed 37/100 conviction; expected move 9.1%. News sentiment 50/100 79 relevant articles in the latest sentiment read. Event risk 0d Next report is scheduled for 30 Jul 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -19.6% below the Trend Line and sits at 1.5% of its 52-week range. The latest completed week returned -18.6%, after a -24.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1012-week average 0.06

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.10Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -24.0% over four weeks, -22.4% over 12 weeks, and -33.8% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-18.6%
4W-24.0%
12W-22.4%
26W-34.6%
52W-33.8%
Active trend streak0 weeks
Active weeks in one year20
Trend breadth38.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.49Latest activity-pressure read.
Pressure change-34.3%Four-week change in activity pressure.
Leadership-38.80Latest relative-leadership reading.
RS change-61.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength3/100Blend of value, momentum, and quality. Underlying universe rank 98; rank 1 is best.
Value20/100Relative valuation strength. Underlying universe rank 81; rank 1 is best.
Quality8/100Profitability and accounting quality. Underlying universe rank 93; rank 1 is best.
Momentum13/100Medium-term price momentum. Underlying universe rank 88; rank 1 is best.
Growth88/100Revenue and earnings growth. Underlying universe rank 13; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
5.6x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-1.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
69.6%
Gross profit retained from each unit of revenue.
Operating margin
-17.9%
Operating profit retained from revenue.
Free-cash-flow margin
-11.4%
Free cash flow generated from revenue.
Return on invested capital
-15.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
69.8%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.0%
Cash dividends relative to market value.
Buyback yield
-2.5%
Net share repurchases relative to market value.
Shareholder yield
-2.5%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-5.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

TEM shows mixed options pressure with a 37/100 conviction score, put-call volume ratio of 0.80, expected move of 9.1%, and Sharemaestro trend signal inactive.

Conviction37/100
Expected move9.1%
Put/call volume0.80
Pressure17
Speculation41
Volatility93
Trend agreement43
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 79 relevant articles.

14 positive · 50 neutral · 15 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings0dNext report is scheduled for 30 Jul 2026; event risk rises as the date approaches.
Options expected move9.1%Nearest-chain priced movement where available.
52-week drawdown-59.1%Distance below the 52-week high.
13-week volatility9.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2616 weeks finished lower.
Best week+30.1%Week of 17 Apr.
Worst week-18.6%Week of 24 Jul.
Latest week-18.6%Week of 24 Jul.

Shape of recent returns

Strong gains9
Modest gains1
Flat weeks0
Modest losses2
Sharp losses14
Recent vol9.2%13-week weekly-return volatility.
Base vol10.0%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew8.7% / -8.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape24/100

Trend, activity pressure, participation, and risk combine to a 24/100 tape read.

 Indicator analysis31/100

Latest 12-week confirmation: trend 0/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.10; No reversal markers Next-Week ExpectancyNegative 43.78%

Next-week expectancy is negative with a 43.78% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors9/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 80; Small Cap Core rank 88 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options44/100

TEM shows mixed options pressure with a 37/100 conviction score, put-call volume ratio of 0.80, expected move of 9.1%, and Sharemaestro trend signal inactive.

Mixed · Options-market disagreement · Expected move 9.1% Sentiment50/100

Weighted news tone is neutral across 79 relevant articles.

Eagle Health Investments LP Takes Position in Tempus AI, Inc. $TEM Insiders50/100

No recent insider transaction evidence is stored.

 Earnings0d

Next report is scheduled for 30 Jul 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202642.69 USD-18.6%53.10 USD57.18 USD0.49-38.8029.5MOff
17 Jul 202652.47 USD-9.9%53.77 USD57.31 USD0.86-26.7019.4MOff
10 Jul 202658.23 USD-3.4%54.17 USD57.36 USD0.90-22.5322.5MOff
3 Jul 202660.27 USD7.4%54.58 USD57.35 USD0.82-18.7028.0MOff
26 Jun 202656.14 USD10.4%55.13 USD57.32 USD0.75-23.9836.5MOff
19 Jun 202650.84 USD6.3%55.85 USD57.33 USD0.61-34.7629.2MOff
12 Jun 202647.82 USD3.0%56.50 USD57.40 USD0.47-37.7032.1MOff
5 Jun 202646.43 USD-8.0%57.19 USD57.49 USD0.39-38.8845.4MOff
29 May 202650.47 USD9.3%58.03 USD57.59 USD0.38-37.1330.4MOff
22 May 202646.18 USD5.1%59.34 USD57.66 USD0.29-41.2124.3MOff
15 May 202643.93 USD-11.9%60.78 USD57.78 USD0.22-43.9832.5MOff
8 May 202649.86 USD-9.3%62.24 USD57.92 USD0.24-37.3243.4MOff
1 May 202655.00 USD5.5%63.79 USD58.00 USD-0.21-27.7520.4MOff
24 Apr 202652.12 USD-6.7%65.01 USD58.03 USD-0.54-30.8924.6MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.